Onkar Bedi
Overview
Explore the profile of Onkar Bedi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bedi O, Sapra V, Kumar M, Krishan P
Mitochondrion
. 2024 Sep;
79:101969.
PMID: 39305943
Liver regeneration is a crucial process involved in cellular proliferation, differentiation, and tissue repair. Calcium signaling impact key pathways like hepatocyte growth factor-Met-tyrosine kinase (HGF-Met) transduction pathway, the epidermal growth...
2.
Chaudhary M, Sharma V, Bedi O, Kaur A, Singh T
Curr Drug Targets
. 2023 Oct;
24(14):1117-1126.
PMID: 37904552
Serum and glucocorticoid-regulated kinases (SGK) are serine/threonine kinases that belong to AGC. The SGK-1, which responds to stress, controls a range of ion channels, cell growth, transcription factors, membrane transporters,...
3.
Aggarwal S, Yadav V, Maiwall R, Rastogi A, Pamecha V, Bedi O, et al.
Biochem Biophys Res Commun
. 2023 Jan;
643:129-138.
PMID: 36603530
There is an alarming increase in incidence of fatty liver disease worldwide. The fatty liver disease spectrum disease ranges from simple steatosis (NAFL) to steatohepatitis (NASH) which culminates in cirrhosis...
4.
Sood A, Bedi O
Inflammopharmacology
. 2022 May;
30(4):1219-1257.
PMID: 35637319
Coronavirus disease 2019 (COVID-19) causes transmissible viral illness of the respiratory tract prompted by the SARS-CoV-2 virus. COVID-19 is one of the worst global pandemics affecting a large population worldwide...
5.
Sharma V, Bedi O, Gupta M, Deshmukh R
Naunyn Schmiedebergs Arch Pharmacol
. 2022 Mar;
395(5):495-513.
PMID: 35258640
Parkinson's disease (PD) is characterized by progressive degeneration of dopaminergic neurons, leading to misbalance and loss of coordination. Current therapies are claimed only for symptomatic relief, on long-term use, which...
6.
Khurana C, Bedi O
Naunyn Schmiedebergs Arch Pharmacol
. 2022 Jan;
395(3):377-380.
PMID: 35076714
Almost every human organ has a poor ability to regenerate, notable exceptions are liver, skin, gut, etc. Molecular and cellular underpinnings of liver regeneration might pave the way for novel...
7.
Gupta M, Krishan P, Kaur A, Arora S, Trehanpati N, Singh T, et al.
Inflamm Res
. 2021 Jul;
70(7):765-776.
PMID: 34212214
Non-alcoholic fatty liver disease (NAFLD) is a multifaceted disease allied with various metabolic disorders, obesity and dysbiosis. Gut microbiota plays an influential role in the pathogenesis of NAFLD and other...
8.
Sardana O, Goyal R, Bedi O
Inflammopharmacology
. 2021 Jun;
29(4):1061-1074.
PMID: 34185201
The liver acts as a manufacturing unit for the production of fetuin-A, which is essential for various physiological characteristics. Scientific research has shown that a moderate upward push in fetuin-A...
9.
Kumar P, Kumar M, Bedi O, Gupta M, Kumar S, Jaiswal G, et al.
Inflammopharmacology
. 2021 Jun;
29(4):1001-1016.
PMID: 34110533
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) known as coronavirus disease (COVID-19), emerged in Wuhan, China, in December 2019. On March 11, 2020, it was declared a global pandemic. As the...
10.
Bedi O, Srivastava N, Parsad D, Krishan P
Eur J Pharmacol
. 2021 Apr;
901:174078.
PMID: 33839087
The abnormal dietary life style leads to hyperlipidemia and insulin resistance with ectopic lipid accumulation and elevated levels of hepatic glucose development which are the underlying pathological characteristics of fatty...